Tag Archives: Editas Medicine

Editas raises $94 million in gene-editing IPO

Editas Medicine’s entry into the stock market with a $94.4 million initial public offering appears to be sparking positive signals for the company as well as the nascent gene-editing industry. That’s not only because the Massachusetts-based startup, which lists Microsoft … Continue reading

Posted in GeekWire | Tagged , , , | Leave a comment

Gene-editing startup Editas files for IPO

Editas Medicine filed the paperwork for an initial public offering today, marking a first for the growing number of private ventures that aim to take advantage of a powerful gene-editing technology known as CRISPR-Cas9. Among Editas’ private investors are Bng0, an investment … Continue reading

Posted in GeekWire | Tagged , , , , , | Leave a comment